J. Wilding

First name
J.
Middle name
P.
Last name
Wilding
Kosiborod, M. ., Cavender, M. A., Fu, A. Z., Wilding, J. P., Khunti, K. ., Holl, R. W., … Fenici, P. . (2017). Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo. Circulation. http://doi.org/10.1161/circulationaha.117.029190
Cavender, M. A., Norhammar, A. ., Birkeland, K. I., Jorgensen, M. E., Wilding, J. P., Khunti, K. ., … Kosiborod, M. . (2018). SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2018.01.085